Veklury

Indicated For

COVID-19

About This Medication

# Gilead Advancing Access Program Guide: Getting Veklury at Low Cost ## What is Veklury? Veklury (remdesivir) is an antiviral medication used to treat COVID-19 in patients who need hospitalization or outpatient care. It's manufactured by Gilead Sciences and can be expensive without assistance. If you've been prescribed Veklury and are concerned about cost, the Gilead Advancing Access Patient Assistance Program may help you get this medication at reduced or no cost. ## Who Can Apply? ### Uninsured Patients If you have no health insurance and have been prescribed Veklury for outpatient COVID-19 treatment, you may qualify for free or reduced-cost medication through this program. ### Insured Patients If you have commercial health insurance (such as Blue Cross, Aetna, or Cigna), you may qualify for a co-pay assistance program that helps reduce your out-of-pocket costs. This program does not apply to patients covered by government insurance programs like Medicare, Medicaid, or Veterans benefits. ### Income Requirements Income limits vary based on your household size and location. The program uses federal poverty guidelines as a baseline but may allow higher income levels depending on circumstances. During the application process, you'll provide your household income, and the program will determine your eligibility. There is no single income cap—it's evaluated on a case-by-case basis. ## What You'll Need to Apply Gather these documents before calling: 1. **Proof of Income**: Recent pay stubs, tax returns, or statements showing your household income 2. **Valid Prescription**: Your doctor's prescription for Veklury 3. **Identification**: A government-issued ID 4. **Insurance Information**: If applicable, your insurance card details (or confirmation of being uninsured) ## How to Apply **Call the Gilead Advancing Access Program directly:** - **Phone**: (800) 226-2056 - **Hours**: Business hours (ask when calling) - **Website**: https://www.gileadadvancingaccess.com/patient/covid-19 **The 4-Step Process:** 1. **Call the number above** and speak with a program representative 2. **Answer questions** about your income, insurance status, and prescription 3. **Provide documentation** as requested (you can submit by phone, mail, or online) 4. **Receive approval and benefits** once your application is processed ## What Happens After You're Approved? Once approved, you'll receive: - Authorization for your pharmacy to dispense Veklury at no or low cost - A program ID or approval code - Instructions on how to use your benefits **Important**: You do not need to reapply if your circumstances haven't changed. The program covers your course of treatment without requiring reauthorization. ## Savings Card Option The program also offers a savings card for eligible patients. This card can reduce your co-pays or medication costs at the pharmacy. Ask the program representative if you qualify for this option during your call. ## What About Biosimilars? Currently, there are no biosimilar versions of Veklury available. Your prescription will be for the original Veklury medication. ## Timeline for Approval Most applications are processed within a few business days, though complex cases may take longer. Ask for an expected timeline when you apply. ## If You Have Government Insurance If you're covered by Medicare, Medicaid, or VA benefits, this co-pay assistance program doesn't apply to you. However, you may still have options: - Contact your insurance provider about coverage of Veklury - Ask your doctor about alternative payment plans - Check if your state has additional assistance programs ## Need Help? If you have questions or need help with your application: - Call (800) 226-2056 - Visit https://www.gileadadvancingaccess.com/patient/covid-19 - Ask your doctor or pharmacy staff for guidance ## Key Takeaway The Gilead Advancing Access Program exists to ensure cost isn't a barrier to getting Veklury when you need it. If you're uninsured or have commercial insurance and are struggling with medication costs, apply today. The process is straightforward, and help is available by phone.

Program information last verified: March 25, 2026